NON-SMALL CELL LUNG CANCER STAGE I
Clinical trials for NON-SMALL CELL LUNG CANCER STAGE I explained in plain language.
Never miss a new study
Get alerted when new NON-SMALL CELL LUNG CANCER STAGE I trials appear
Sign up with your email to follow new studies for NON-SMALL CELL LUNG CANCER STAGE I, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Blood test guides targeted therapy to prevent lung cancer return
Disease control Recruiting nowThis study looks at people with early-stage non-small cell lung cancer who have finished standard treatment. A blood test checks for tiny bits of cancer DNA (ctDNA) that might mean the cancer could come back. If the test is positive, participants get a drug called durvalumab to t…
Matched conditions: NON-SMALL CELL LUNG CANCER STAGE I
Phase: PHASE2 • Sponsor: Stanford University • Aim: Disease control
Last updated Jun 15, 2026 19:07 UTC
-
New combo aims to shield scarred lungs during cancer radiation
Disease control Recruiting nowThis study tests whether adding BIO 300 to standard chest radiation can prevent severe lung inflammation (pneumonitis) in people with early-stage non-small cell lung cancer who also have interstitial lung disease (scarred lungs). About 25 participants will receive the drug alongs…
Matched conditions: NON-SMALL CELL LUNG CANCER STAGE I
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 08, 2026 13:11 UTC